Radiopharmaceutical evaluation of ¹³¹I-protohypericin as a necrosis avid compound

References

• Spikes JD, Jori G. Photodynamic therapy of tumours and other diseases using porphyrins. Laser Med Sci 1987;2:3–15
   Google Scholar
• Ni Y. Metalloporphyrins and functional analogues as MRI contrast agents. Curr Med Imaging Rev 2008;4:96–112
   Web of Science ®Google Scholar
• Ni Y, Marchal G, Yu J, et al. Localization of metalloporphyrin-induced “specific” enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings. Acad Radiol 1995;2:687–99
   PubMed Web of Science ®Google Scholar
• Klaus Linde, Gilbert Ramirez, Cynthia D Mulrow, et al. St John's wort for depression-an overview and meta-analysis of randomised clinical trials. Br Med J 1996;313:253–8
   Google Scholar
• Yip L, Hudson JB, Gruszecka-Kowalik E, et al. Antiviral activity of a derivative of the photosensitive compound hypericin. Phytomedicine 1996;3:185–90
   PubMed Web of Science ®Google Scholar
• Wei Zhang, Ronald E. Law, David R. Hinton, et al. Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett 1997;120:31–8
   Google Scholar
• Utsumi T, Okuma M, Kanno T, et al. Effect of the antiretroviral agent hypericin on rat liver mitochondria. Biochem Pharmacol 1995;50:655–62
   PubMed Web of Science ®Google Scholar
• Bin Chen and Witte PAd. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. Cancer Lett 2000;150:111–17
   Google Scholar
• Sanovic R, Verwanger T, Hartl A, et al. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma. Photodiagn Photodyn Ther 2011;8:291–6
   PubMed Web of Science ®Google Scholar
• Ni Y, Huyghe D, Verbeke K, et al. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent. Eur J Nucl Med Mol Imaging 2006;33:595–601
   PubMed Web of Science ®Google Scholar
• Marysael T, Bauwens M, Ni Y, et al. Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy. Invest New Drug 2012;30:2132–40
   PubMed Web of Science ®Google Scholar
• Bano G, Stanicova J, Jancura D, et al. On the diffusion of hypericin in dimethylsulfoxide/water mixtures-the effect of aggregation. J Phys Chem B 2011;115:2417–23
   PubMed Web of Science ®Google Scholar
• Van De Putte M, Roskams T, Bormans G, et al. The impact of aggregation on the biodistribution of hypericin. Int J Oncol 2006;28:655–60
   PubMed Web of Science ®Google Scholar
• Kong M, Zhang J, Jiang C, et al. Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis. J Drug Target 2013;21:604–10
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Hashimoto Y. Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry. J Med Chem 2011;54:1539–54
   PubMed Web of Science ®Google Scholar
• Saeki M, Ishiuchi S-i, Sakai M, et al. Structure of the jet-cooled 1-naphthol dimer studied by IR dip spectroscopy: cooperation between the π–π interaction and the hydrogen bonding. J Phys Chem A 2007;111:1001–5
   PubMed Web of Science ®Google Scholar
• Fonge H, Jin L, Wang H, et al. Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent. Bioorg Med Chem Lett 2007;17:4001–5
   PubMed Web of Science ®Google Scholar
• Lewin G, Maciuk A, Moncomble Al, et al. Enhancement of the water solubility of flavone glycosides by disruption of molecular planarity of the aglycone moiety. J Nat Prod 2012;76:8–12
   PubMed Web of Science ®Google Scholar
• Kamuhabwa A, Augustijns P, De Witte P. In vitro transport and uptake of protohypericin and hypericin in the Caco-2 model. Int J Pharm 1999;188:81–6
   PubMed Web of Science ®Google Scholar
• Delaey EM, Kamuhabwa AR, Vandenbogaerde AL, et al. Photocytotoxicity of protohypericin after photoconversion to hypericin. Planta Med 1999;65:719–22
   PubMed Web of Science ®Google Scholar
• Yasuda T, Yamaki M, Iimura A, et al. Anti-influenza virus principles from Muehlenbeckia hastulata. J Nat Med 2010;64:206–11
   PubMed Web of Science ®Google Scholar
• Falk H, Meyer J, Oberreiter M. A convenient semisynthetic route to hypericin. Monatsh Chem 1993;124:339–41
   Web of Science ®Google Scholar
• Falk H, Meyer J. On the homo-and heteroassociation of hypericin. Monatsh Chem 1994;125:753–62
   Web of Science ®Google Scholar
• Wu X, Wang H, Chen F, et al. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology. Acta Radiol 2009;50:276–87
   PubMed Web of Science ®Google Scholar
• Ni Y, Petré C, Miao Y, et al. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. Invest Radiol 1997;32:770–9
   PubMed Web of Science ®Google Scholar
• Piperopoulos G, Lotz R, Wixforth A, et al. Determination of naphthodianthrones in plant extracts from Hypericum perforatum L. by liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 1997;695:309–16
   PubMed Web of Science ®Google Scholar
• Banks H, Cameron D, Raverty W. Chemistry of the Coccoidea. II. Condensed polycyclic pigments from two Australian pseudococcids (Hemiptera). Aust J Chem 1976;29:1509–21
   Web of Science ®Google Scholar
• Volkert WA, Hoffman TJ. Terapeutic radiopharmaceuticals. Chem Rev 1999;99:2269–92
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang C, Jiang X, et al. The research on biodistribution of 131 I-Iodo sennoside A in normal mice and to evaluate myocardial activity. J Isotopes 2013;26:98–103
   Google Scholar
• Xiao W, Wei ZL. Stability of hypericin. Guangpu Shiyanshi 2005;22:797–800
   Google Scholar
• Lewin G, Maciuk A, Moncomble A, et al. Enhancement of the water solubility of flavone glycosides by disruption of molecular planarity of the aglycone moiety. J Nat Prod 2013;76:8–12
   PubMed Web of Science ®Google Scholar
• Haedler AT, Misslitz H, Buehlmeyer C, et al. Controlling the π-stacking behavior of pyrene derivatives: influence of h-bonding and steric effects in different states of aggregation. ChemPhysChem 2013;14:1818–29
   PubMed Web of Science ®Google Scholar
• Yao S, Beginn U, Gress T, et al. Supramolecular polymerization and gel formation of bis-(merocyanine) dyes driven by dipolar aggregation. J Am Chem Soc 2004;126:8336–48
   PubMed Web of Science ®Google Scholar
• Shetty AS, Zhang J, Moore JS. Aromatic π-stacking in solution as revealed through the aggregation of phenylacetylene macrocycles. J Am Chem Soc 1996;118:1019–27
   Web of Science ®Google Scholar
• Liu X, Jiang C, Li Y, et al. Evaluation of hypericin: effect of aggregation on targeting biodistribution. J Pharm Sci 2015;104:215–22
   Google Scholar
• Khawli LA, Hu P, Epstein AL. Multiple uses of tumor necrosis therapy (TNT) for the treatment and imaging of solid tumors: preclinical considerations and progress. Update Cancer Therapeut 2006;1:33–47
   Google Scholar
• Li J, Cona MM, Chen F, et al. Diverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology. Transl Oncol 2013;6:42–50
   PubMed Web of Science ®Google Scholar
• Li J, Cona MM, Chen F, et al. Sequential systemic administrations of combretastatin A4 phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts. Theranostics 2013;3:127–37
   PubMed Web of Science ®Google Scholar